My NCBI | Sign In
RSS Settings
  • Search: Haskins K[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 85

    1.

    Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner.

    Tonkin DR, Haskins K.

    Eur J Immunol. 2009 May;39(5):1313-22.PMID: 19404982 [PubMed - indexed for MEDLINE]Related articles

    2.

    Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains.

    Zhang L, Jasinski JM, Kobayashi M, Davenport B, Johnson K, Davidson H, Nakayama M, Haskins K, Eisenbarth GS.

    J Autoimmun. 2009 Aug;33(1):42-9. Epub 2009 Mar 16.PMID: 19286348 [PubMed - in process]Related articles

    3.

    Carbon monoxide poisoning measurement.

    Harty E, Haskins K, Robinson K.

    Emerg Med J. 2008 Dec;25(12):862. No abstract available. PMID: 19033522 [PubMed - indexed for MEDLINE]Related articles

    4.

    CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.

    Baker RL, Wagner DH Jr, Haskins K.

    J Autoimmun. 2008 Dec;31(4):385-92. Epub 2008 Oct 31.PMID: 18951762 [PubMed - indexed for MEDLINE]Related articles

    5.

    Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.

    Tonkin DR, He J, Barbour G, Haskins K.

    J Immunol. 2008 Oct 1;181(7):4516-22.PMID: 18802054 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Unfolded protein response genes regulated by CED-1 are required for Caenorhabditis elegans innate immunity.

    Haskins KA, Russell JF, Gaddis N, Dressman HK, Aballay A.

    Dev Cell. 2008 Jul;15(1):87-97.PMID: 18606143 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    On the pathogenicity of autoantigen-specific T-cell receptors.

    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.

    Diabetes. 2008 May;57(5):1321-30. Epub 2008 Feb 25.PMID: 18299317 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha.

    He J, Haskins K.

    Immunology. 2008 Jan;123(1):108-17. Epub 2007 Nov 5.PMID: 17983440 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1.

    Cantor J, Haskins K.

    J Immunol. 2007 Nov 1;179(9):5760-7.PMID: 17947648 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oxidant stress, immune dysregulation, and vascular function in type I diabetes.

    Nicolls MR, Haskins K, Flores SC.

    Antioxid Redox Signal. 2007 Jul;9(7):879-89. Review.PMID: 17508913 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides.

    Weber LM, Hayda KN, Haskins K, Anseth KS.

    Biomaterials. 2007 Jul;28(19):3004-11. Epub 2007 Mar 14.PMID: 17391752 [PubMed - indexed for MEDLINE]Related articles

    12.

    Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.

    Szczepankiewicz BG, Kosogof C, Nelson LT, Liu G, Liu B, Zhao H, Serby MD, Xin Z, Liu M, Gum RJ, Haasch DL, Wang S, Clampit JE, Johnson EF, Lubben TH, Stashko MA, Olejniczak ET, Sun C, Dorwin SA, Haskins K, Abad-Zapatero C, Fry EH, Hutchins CW, Sham HL, Rondinone CM, Trevillyan JM.

    J Med Chem. 2006 Jun 15;49(12):3563-80.PMID: 16759099 [PubMed - indexed for MEDLINE]Related articles

    13.

    PEG-based hydrogels as an in vitro encapsulation platform for testing controlled beta-cell microenvironments.

    Weber LM, He J, Bradley B, Haskins K, Anseth KS.

    Acta Biomater. 2006 Jan;2(1):1-8. Epub 2005 Dec 20.PMID: 16701853 [PubMed - indexed for MEDLINE]Related articles

    14.

    T cells to a dominant epitope of GAD65 express a public CDR3 motif.

    Quinn A, McInerney M, Huffman D, McInerney B, Mayo S, Haskins K, Sercarz E.

    Int Immunol. 2006 Jun;18(6):967-79. Epub 2006 Apr 26.PMID: 16641112 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. 1983.

    Kappler J, Kubo R, Haskins K, Hannum C, Marrack P, Pigeon M, McIntyre B, Allison J, Trowbridge I.

    J Immunol. 2006 Mar 1;176(5):2683-90. No abstract available. PMID: 16493022 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5.

    Phillips JM, Haskins K, Cooke A.

    Immunology. 2005 Dec;116(4):525-31.PMID: 16313366 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha.

    Cantor J, Haskins K.

    J Immunol. 2005 Dec 1;175(11):7738-45.PMID: 16301684 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Alterations in redox homeostasis and prostaglandins impair endothelial-dependent vasodilation in euglycemic autoimmune nonobese diabetic mice.

    Ling X, Cota-Gomez A, Flores NC, Hernandez-Saavedra D, McCord JM, Marecki JC, Haskins K, McDuffie M, Powers K, Kench J, Oka M, McMurtry I, Flores SC.

    Free Radic Biol Med. 2005 Oct 15;39(8):1089-98.PMID: 16198235 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse.

    Haskins K.

    Adv Immunol. 2005;87:123-62. Review.PMID: 16102573 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence for mutualist limitation: the impacts of conspecific density on the mycorrhizal inoculum potential of woodland soils.

    Haskins KE, Gehring CA.

    Oecologia. 2005 Aug;145(1):123-31. Epub 2005 May 11.PMID: 15891858 [PubMed - indexed for MEDLINE]Related articles

    21.

    T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes.

    Pauza ME, Dobbs CM, He J, Patterson T, Wagner S, Anobile BS, Bradley BJ, Lo D, Haskins K.

    Diabetes. 2004 Apr;53(4):978-88.PMID: 15047613 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Role for oxidative stress in the regeneration of islet beta cells?

    Haskins K, Kench J, Powers K, Bradley B, Pugazhenthi S, Reusch J, McDuffie M.

    J Investig Med. 2004 Jan;52(1):45-9. Review.PMID: 14989369 [PubMed - indexed for MEDLINE]Related articles

    23.

    T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.

    Haskins K.

    J Autoimmun. 2004 Mar;22(2):107-9. Review. No abstract available. PMID: 14987737 [PubMed - indexed for MEDLINE]Related articles

    24.

    Oxidative stress in type 1 diabetes.

    Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, Pugazhenthi S, Reusch J, Kench J.

    Ann N Y Acad Sci. 2003 Nov;1005:43-54.PMID: 14679039 [PubMed - indexed for MEDLINE]Related articles

    25.

    Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

    Stratmann T, Martin-Orozco N, Mallet-Designe V, Poirot L, McGavern D, Losyev G, Dobbs CM, Oldstone MB, Yoshida K, Kikutani H, Mathis D, Benoist C, Haskins K, Teyton L.

    J Clin Invest. 2003 Sep;112(6):902-14.PMID: 12975475 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.

    Roberts SA, Barbour G, Matarrese MR, Mason DL, Leiter EH, Haskins K, Hanson MS.

    J Autoimmun. 2003 Sep;21(2):139-47.PMID: 12935783 [PubMed - indexed for MEDLINE]Related articles

    27.

    Community-level physiological profiles of bacteria and fungi: plate type and incubation temperature influences on contrasting soils.

    Classen AT, Boyle SI, Haskins KE, Overby ST, Hart SC.

    FEMS Microbiol Ecol. 2003 Jun 1;44(3):319-28.PMID: 19719613 [PubMed - in process]Related articles

    28.

    Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery.

    Vaitaitis GM, Poulin M, Sanderson RJ, Haskins K, Wagner DH Jr.

    J Immunol. 2003 Apr 1;170(7):3455-9.PMID: 12646605 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.

    Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD.

    J Pharmacol Exp Ther. 2003 Mar;304(3):1209-16.PMID: 12604698 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Prednisolone inhibits LPS-induced bone marrow suppressor cell activity in vitro but not in vivo.

    Haskins KA, Schlauder SM, Holda JH.

    Int Immunopharmacol. 2003 Feb;3(2):169-78.PMID: 12586598 [PubMed - indexed for MEDLINE]Related articles

    31.

    Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.

    Yoshida K, Martin T, Yamamoto K, Dobbs C, Münz C, Kamikawaji N, Nakano N, Rammensee HG, Sasazuki T, Haskins K, Kikutani H.

    Int Immunol. 2002 Dec;14(12):1439-47.PMID: 12456592 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

    Wagner DH Jr, Vaitaitis G, Sanderson R, Poulin M, Dobbs C, Haskins K.

    Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3782-7. Epub 2002 Mar 12.PMID: 11891296 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone.

    Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K.

    Diabetes. 2002 Feb;51(2):347-55.PMID: 11812741 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Report from the 1st International NOD Mouse T-Cell Workshop and the follow-up mini-workshop.

    Kaufman DL, Tisch R, Sarvetnick N, Chatenoud L, Harrison LC, Haskins K, Quinn A, Sercarz E, Singh B, von Herrath M, Wegmann D, Wen L, Zekzer D.

    Diabetes. 2001 Nov;50(11):2459-63. Review.PMID: 11679422 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Prediction of diabetes and response to therapy in individual animals: are there lessons for man? Report on the JDF/Snow Mountain Meeting, 5-7 October 2000, Winter Park, CO, USA.

    Haskins K, Atkinson M.

    J Autoimmun. 2001 Feb;16(1):15-9. No abstract available. PMID: 11221992 [PubMed - indexed for MEDLINE]Related articles

    36.

    Comparison of a T cell clone and of T cells from a TCR transgenic mouse: TCR transgenic T cells specific for self-antigen are atypical.

    Dobbs C, Haskins K.

    J Immunol. 2001 Feb 15;166(4):2495-504.PMID: 11160310 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells.

    Phillips JM, Harach SZ, Parish NM, Fehervari Z, Haskins K, Cooke A.

    J Immunol. 2000 Aug 15;165(4):1949-55.PMID: 10925277 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients.

    Tree TI, O'Byrne D, Tremble JM, MacFarlane WM, Haskins K, James RF, Docherty K, Hutton JC, Banga JP.

    Clin Exp Immunol. 2000 Jul;121(1):100-5.PMID: 10886245 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones.

    Bergman B, McManaman JL, Haskins K.

    J Autoimmun. 2000 Jun;14(4):343-51.PMID: 10882061 [PubMed - indexed for MEDLINE]Related articles

    40.

    Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.

    Piganelli JD, Poulin M, Martin T, Allison JP, Haskins K.

    J Autoimmun. 2000 Mar;14(2):123-31.PMID: 10677243 [PubMed - indexed for MEDLINE]Related articles

    41.

    Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse.

    Poulin M, Haskins K.

    J Immunol. 2000 Mar 15;164(6):3072-8.PMID: 10706696 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes.

    Rosmalen JG, Martin T, Dobbs C, Voerman JS, Drexhage HA, Haskins K, Leenen PJ.

    Lab Invest. 2000 Jan;80(1):23-30.PMID: 10652999 [PubMed - indexed for MEDLINE]Related articles

    43.

    T cell receptor gene usage in autoimmune diabetes.

    Haskins K.

    Int Rev Immunol. 1999;18(1-2):61-81. Review. No abstract available. PMID: 10614739 [PubMed - indexed for MEDLINE]Related articles

    44.

    Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes.

    Fossati G, Cooke A, Papafio RQ, Haskins K, Stockinger B.

    J Exp Med. 1999 Aug 16;190(4):577-83.PMID: 10449528 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Interleukin-13 prevents autoimmune diabetes in NOD mice.

    Zaccone P, Phillips J, Conget I, Gomis R, Haskins K, Minty A, Bendtzen K, Cooke A, Nicoletti F.

    Diabetes. 1999 Aug;48(8):1522-8.PMID: 10426368 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Analysis of leukocytes recruited to the pancreas by diabetogenic T cell clones.

    Peterson JD, Berg R, Piganelli JD, Poulin M, Haskins K.

    Cell Immunol. 1998 Nov 1;189(2):92-8.PMID: 9790722 [PubMed - indexed for MEDLINE]Related articles

    47.

    Splenic macrophages from the NOD mouse are defective in the ability to present antigen.

    Piganelli JD, Martin T, Haskins K.

    Diabetes. 1998 Aug;47(8):1212-8.PMID: 9703319 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Maternal immunization with a soluble TCR-Ig chimeric protein: long term, V beta-8 family-specific suppression of T cells by maternally transferred antibodies.

    McKeever U, Khandekar S, Jesson M, Newcomb J, Gregory P, Naylor J, Haskins K, Jones B.

    J Immunol. 1997 Dec 15;159(12):5936-45.PMID: 9550391 [PubMed - indexed for MEDLINE]Related articles

    49.

    Autoreactive T-cell clones from the nonobese diabetic mouse.

    Bergman B, Haskins K.

    Proc Soc Exp Biol Med. 1997 Jan;214(1):41-8. Review.PMID: 9012359 [PubMed - indexed for MEDLINE]Related articles

    50.

    Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein:antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization.

    McKeever U, Khandekar S, Newcomb J, Naylor J, Gregory P, Brauer P, Jesson M, Bettencourt B, Burke E, Alderson A, Banerji J, Haskins K, Jones B.

    J Exp Med. 1996 Nov 1;184(5):1755-68.PMID: 8920864 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    15 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity